معرفی
Kristel Muijs is a Researcher at the University of Groningen's Faculty of Medical Sciences, affiliated with the Onco-Immunology (O-I) and Personalized Cancer Treatment (PCT) departments. Her work focuses on advancing cancer therapy, particularly in esophageal and thoracic malignancies. She specializes in radiation oncology, proton therapy, and the cardiac and pulmonary effects of radiotherapy. Dr. Muijs leads clinical trials and cohort studies evaluating treatment outcomes and biomarkers of therapeutic efficacy.
Her research addresses critical areas such as reducing pneumonia in esophageal cancer patients through proton therapy and monitoring cardiac damage during radiotherapy. She collaborates internationally and actively contributes to peer-review and academic presentations. Muijs has over 109 publications and has presented at numerous conferences, emphasizing translational research to improve patient care.
Notably, she supervises PhD students and engages in interdisciplinary projects, bridging clinical practice and scientific innovation. Her work aligns with UN Sustainable Development Goals aimed at improving health equity and reducing the global burden of diseases.
